Join
Live feed
·
INSIDERFilingvia Quantisnow
Tango Therapeutics Inc. logo

Director Azelby Robert was granted 5,740 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TNGX· Tango Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNGX (Tango Therapeutics Inc.) and more on Quantisnow.

Director Azelby Robert was granted 5,740 shares (SEC Form 4) | Quantisnow